Insider Transactions Reported by 10 Insiders of CytoMed Therapeutics Ltd

Symbol
GDTC on Nasdaq
Location
1 Commonwealth Lane, Singapore

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

CytoMed Therapeutics Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lucas Tien Wee Luk Chief Clinical Officer, Director 31 Mar 2023
Keng Kiat Toh Director 31 Mar 2023
Jieming Zeng CSO and CMO, Director 31 Mar 2023
Shu Wang 10%+ Owner 31 Mar 2023
Chee Kong Choo Director, 10%+ Owner 31 Mar 2023
Mark Kei Wei Leong Director 31 Mar 2023
Glorious Finance Ltd 10%+ Owner 31 Mar 2023
Wee Kiat Tan Chief Operating Officer, Director 31 Mar 2023
Chak Hua Yew Director 31 Mar 2023
Yuin Han Loh Director 31 Mar 2023

Recent Insider Transactions by Companies or Individuals for CytoMed Therapeutics Ltd

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Chee Kong Choo GDTC Ordinary Shares, no par value per share 0 410,515 31 Mar 2023 See footnote
Chee Kong Choo GDTC Ordinary Shares, no par value per share 0 2,559,482 31 Mar 2023 See footnote
Lucas Tien Wee Luk GDTC Ordinary Shares, no par value per share 0 92,563 31 Mar 2023 Direct
Shu Wang GDTC Ordinary Shares, no par value per share 0 883,858 31 Mar 2023 Direct
Jieming Zeng GDTC Ordinary Shares, no par value per share 0 589,239 31 Mar 2023 Direct
Glorious Finance Ltd GDTC Ordinary Shares, no par value per share 0 4,653,604 31 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.